Archer-Daniels-Midland Company (ADM)

Rating: HOLD

HOLD (5-tier) · quality defensive · conviction: low

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).

Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = HOLD because:

• Probability-weighted scenario value implies +0% vs spot
• Monte Carlo median implies -11% vs spot
• DCF fair value implies -50% vs spot
• Bear case (Structural — Crush / Protein Margin Reset) downside is -64% vs spot
• Net: reward/risk of 0.4× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Investment Thesis

At $76.40 (26 June 2026) ADM trades on roughly 16.6x forward earnings, a premium to the 14.4x peer median. The market is paying for normalised crush and protein margins persisting, and giving credit for the cost and portfolio discipline management has promised. The engine is less generous. Forty per cent of the scenario weight sits on margin-reset or trough paths, and the Monte Carlo assigns only a 44.8% probability to fair value above spot. The DCF anchor is $40.43 per share: a circa 3% operating margin on $80.6bn of revenue leaves modest free cash after $1.2-1.6bn of capex (FY2025 actual $1.248bn, AV as of 2025-12-31), so much of the equity case rests on the multiple rather than on cash generation. The probability-weighted target of $78.37 sits within 3% of spot, hence HOLD. The single most damaging risk is a structural crush-capacity overbuild: that scenario prices at $27.51, below the 52-week low of $50.07.

The dashboard below is the whole argument on one page: spot ($78) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The bear mechanism is capacity, not demand. North and South American soybean crush capacity has been built out on renewable-diesel expectations; if biofuel policy support softens while the new plants keep running, crush margins reset structurally rather than cyclically. ADM earns roughly three cents of operating profit per revenue dollar, so a one-point margin reset removes about a third of earnings — and the market will not hold a 17x multiple on a processor it has reclassified as structurally impaired with $10.1bn of net debt. Nutrition has not delivered its promised diversification, and the 2024 intersegment-accounting episode gives sceptics grounds to discount reported segment margins altogether. On those drivers the scenario prices near $27.51, earnings and multiple compressing together, below the 52-week low.

Key Debate

Gross Margin explains 68% of Monte Carlo outcome variance — the single variable that decides which side is right.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.43 vs analyst floor +0.05 → delta +0.38 (n=23 mgmt / 16 Q&A; 49th pctile across the S&P book, z -0.1).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

News (last 365d, 1000 articles): avg ticker sentiment +0.12 (bullish 17% / bearish 6%)

Scenario Analysis

The tree runs from a structural 'Structural — Crush / Protein Margin Reset' downside ($28) to a 'Spike — Supply Dislocation' bull case ($155); the probability-weighted blend (PWEV $78) is +0% versus spot.

Scenario rationale — what each probability buys (the driver path behind every target):

• Structural — Crush / Protein Margin Reset (22%, $28). Structural impairment — crush / protein margin reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 27.51; probability: 0.22.
• Cyclical Margin Trough (18%, $48). Cyclical downturn — ag-processing crush margins / protein cycle + commodity & feed costs weakens for 1–2 years before normalising. Drivers — implied_target: 48.98; probability: 0.18.
• Base — Mid-Cycle Crush / Protein Margins (32%, $80). Mid-cycle — normalised ag-processing crush margins / protein cycle + commodity & feed costs; disciplined capital allocation; steady returns. Drivers — implied_target: 79.52; probability: 0.32.
• Upcycle — Tight Margins (20%, $127). Upside — tight crush / protein margins lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 126.83; probability: 0.2.
• Spike — Supply Dislocation (8%, $155). Upside tail — sustained tight conditions or a structural re-rate on tight crush / protein margins. Drivers — implied_target: 158.63; probability: 0.08.

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $70 + scenario PWEV $78, ≈ spot); the weighted blend $59 (-24%) sits below it because the cash-flow DCF ($39) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $70 and 43% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (68% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 9.0%, 14x terminal FCF multiple → $39. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 14.375x) implies $66. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Across all anchors the spread is 271% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Industry Context — Consumer Staples — Ag

This name sits in the Consumer Staples — Ag as a ag_products. ag-processing crush margins / protein cycle + commodity & feed costs Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: ADM (ag_products) · BG (ag_products) · TSN (ag_products)

Mapping note: name-level 'Structural — Crush / Protein Margin Reset' (22%) + 'Cyclical Margin Trough' (18%) map to cluster Crush / Protein Margin Reset (40%); name-level 'Upcycle — Tight Margins' (20%) + 'Spike — Supply Dislocation' (8%) map to cluster Tight-Margin Upcycle (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Crush / Protein Margin Reset () — this name implies 40% vs the cluster house view of 40% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The staples_ag cycle is the shared macro driver. Driver — ag-processing crush margins / protein cycle + commodity & feed costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 6% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 9.0% · Σ PV(FCF) $9B + PV(terminal) $21B = EV $29B; + net cash → equity $19B ÷ diluted shares 0.48B = $39/share (exit-multiple terminal).

• Gordon (perpetuity-growth) terminal at 2.5% → $45/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
• Incremental ROIC on the forecast capex ≈ 3% vs WACC 9% → below WACC — the incremental build is value-dilutive.

Peer set

Peer-median fwd P/E → $66; EV/Rev → $228.

Weighted fair-value math

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × op-margin Δ

Tornado — DCF/share swing by driver (widest first)

Company lever — SoP/share vs Agricultural Products & Protein multiple (AI re-rating) (base 17x)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 0.1% of revenue; cash conversion (OCF/NI) 508% — cash-backed.

Catalyst Calendar

• 2026-02-03 (~-155d) — FY2025 full-year results and FY2026 crush/protein margin guide (authored)
• 2026-08-04 (~27d) — Quarterly earnings — est. EPS $1.29 (AV EARNINGS_CALENDAR)
• 2026-09-15 (~69d) — Renewable diesel / biofuel policy (RVO, 45Z credit) decision window (authored)
• 2027-01-12 (~188d) — Nutrition segment restructuring / portfolio update (authored)

Forecast Track Record

• EPS surprise: beat 50.0% of the last 8 quarters; average surprise +2.3%.

Competitive Moat

Narrow moat. ADM's advantage is scale in origination, logistics and crush capacity, not pricing power; margins are set by the crush/protein spread, not the franchise. FALSIFIABLE: if trailing crush margins mean-revert to mid-cycle and ROIC fails to exceed WACC across a full cycle, the terminal multiple should sit at or below the commodity-processor ~13-14x, not a premium.

Moat sources:

• Global grain origination and logistics network (barges, elevators, ports) - hard to replicate but low margin
• Crush capacity scale in soy/corn - cost advantage, not price-setting power
• Nutrition segment brand/formulation IP (the only genuine margin franchise, still small)
• No durable pricing power: margins are spread-driven and mean-reverting

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

What the Market Is Pricing In

At the current price, the market pays 14.6× forward EPS, vs the house DCF terminal 14.0×, and a peer median 14.375×. The house DCF sits 50% below spot, so the market is pricing in more than the house case — roughly 3.4pp of revenue CAGR.

Variant perception: the house view is above-consensus, and the thesis is primarily event-driven.

Peer Quality & Weighting

Quality-weighted forward P/E: 14.5× (simple median 14.375×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $50–$85, centre $65 (-16% vs spot); spot sits at the 80th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Spike — Supply Dislocation): $155.

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (108.0); Revenue CAGR ±3pp (17.0); Terminal × ±15% (13.0); Capex intensity ±15% (13.0); WACC ±1pp (5.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Source Log

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

DCF: WACC 9%, terminal multiple 14×, FY+5 revenue $86B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Ag Services & Oilseeds segment operating profit (YoY) < -0.2 (2 consecutive prints → Crush / Protein Margin Reset). The base case assumes normalised crush margins (revenue growth of 2%, operating margin near 3.4%). Two consecutive quarters of segment operating profit down more than 20% YoY sits between the base and trough driver paths and signals the crush cycle rolling onto the reset path.
• Companywide operating margin (segment operating profit / revenue) < 0.03 (2 consecutive prints → Crush / Protein Margin Reset). 3.0% is the midpoint of the base (3.36%) and cyclical-trough (2.6%) margin assumptions. Two prints below it falsify the mid-cycle margin that carries the $79.52 base target.
• Revenue growth (YoY) < -0.005 (2 consecutive prints → Crush / Protein Margin Reset). -0.5% is the midpoint of the base (growth of 2%) and cyclical-trough (-3%) growth drivers. Sustained contraction indicates volumes and pricing rolling over together, not a one-quarter timing effect.
• Operating cash flow, trailing four quarters ($B) < 2.3 (2 consecutive prints → Crush / Protein Margin Reset). The FY25 dividend (~$0.99B) plus the ~$1.3B capex run-rate requires roughly $2.3B of operating cash flow. Below that line, with $10.07B of net debt, the payout is funded from the balance sheet and the capital-returns leg of the thesis fails.
• New material accounting restatement or SEC enforcement action on segment reporting (count) >= 1 (single event → Crush / Protein Margin Reset). The 2024 intersegment-pricing investigation forced a restatement and removed the CFO. A recurrence would impair confidence in reported segment economics and maps directly to the multiple-compression leg of the structural scenario.

Fact / Inference / Speculation

• FACT: Spot $78; 52-week range $50–$85; engine rating HOLD; base-case target $78 (+0%). (source: Alpha Vantage 2026-06-26, 8 July 2026)
• INFERENCE: Triangulated FV $59 (-24% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Recommendation: HOLD

Balanced: triangulated fair value $59 (-24% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin — a fundamental call.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

• No suitability assessment has been performed for any individual.
• Market data may be delayed or inaccurate; figures are as of the analysis date.
• Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
• Forecasts are uncertain; past performance is not indicative of future returns.
• The author or publisher may hold positions in securities mentioned.
• Users should verify information against primary sources (company filings) before acting.
• Investing involves risk of loss; there is no guarantee any target price is achieved.
• Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.